Rxi Pharmaceuticals (RXII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXII | ZTS | TAK | NBIX | UTHR |
| Company | Rxi Pharmaceuticals | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | United Therapeutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 0.33 | 158.42 | 13.15 | 136.05 | 234.76 |
| High | 0.33 | 165.04 | 13.19 | 138.16 | 238.37 |
| Low | 0.32 | 158.42 | 13.13 | 136.05 | 234.76 |
| Last | 0.33 | 163.13 | 13.12 | 136.73 | 238.04 |
| Change | unch | +4.71 | +0.09 | +0.74 | +4.19 |
| % Change | unch | +2.97% | +0.69% | +0.54% | +1.79% |
| Volume | 461,100 | 1,540,031 | 206,906 | 93,133 | 42,832 |
| 20-Day Average Volume | 1,725,540 | 4,247,109 | 1,699,474 | 720,021 | 453,641 |
| Previous Close | 0.33 | 158.42 | 13.03 | 135.99 | 233.85 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.41 | 157.22 | 13.36 | 136.25 | 234.96 |
| 20-Day Raw Stochastic | 10.53% | 79.18% | 16.23% | 47.48% | 78.70% |
| 20-Day Relative Strength | 30.13% | 49.65% | 36.33% | 51.15% | 53.84% |
| Weighted Alpha | -94.27 | -13.47 | -22.11 | +40.19 | +10.95 |
| Today's Opinion | N/A | 72% Sell | 100% Sell | 80% Buy | 80% Buy |
| Previous Opinion | N/A | 72% Sell | 100% Sell | 48% Buy | 64% Buy |
| Last Month's Opinion | N/A | 40% Sell | 72% Sell | 88% Buy | 16% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -23.26% since 11/09/18 | +12.87% since 04/22/24 | -1.72% since 04/22/24 | +2.64% since 04/22/24 | +1.69% since 04/22/24 |
| Low | 0.31 on 11/15/18 | 145.18 on 04/23/24 | 13.01 on 04/26/24 | 135.17 on 04/26/24 | 233.27 on 04/24/24 |
| High | 0.41 on 11/12/18 | 164.27 on 04/29/24 | 13.41 on 04/23/24 | 145.00 on 04/23/24 | 241.00 on 04/24/24 |
| 1-Month | |||||
| %Chg | -26.67% since 10/16/18 | -2.92% since 03/28/24 | -5.47% since 03/28/24 | -0.53% since 03/28/24 | +3.61% since 03/28/24 |
| Low | 0.31 on 11/15/18 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 130.13 on 04/19/24 | 221.53 on 04/01/24 |
| High | 0.50 on 11/08/18 | 169.49 on 04/01/24 | 13.78 on 04/01/24 | 145.00 on 04/23/24 | 241.37 on 04/11/24 |
| 3-Month | |||||
| %Chg | -78.29% since 08/16/18 | -14.78% since 01/29/24 | -11.10% since 01/29/24 | -3.54% since 01/29/24 | +9.73% since 01/29/24 |
| Low | 0.31 on 11/15/18 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 128.00 on 02/07/24 | 208.62 on 02/08/24 |
| High | 2.19 on 09/27/18 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 148.37 on 03/21/24 | 250.89 on 03/26/24 |
| 6-Month | |||||
| %Chg | -86.08% since 05/16/18 | +5.28% since 10/27/23 | -2.52% since 10/27/23 | +29.34% since 10/27/23 | +8.57% since 10/27/23 |
| Low | 0.31 on 11/15/18 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 103.63 on 11/10/23 | 208.62 on 02/08/24 |
| High | 2.84 on 05/18/18 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 148.37 on 03/21/24 | 258.31 on 12/14/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,445 | 72,454,816 | 41,237,580 | 13,531,958 | 11,004,745 |
| Shares Outstanding, K | 4,380 | 457,359 | 3,164,818 | 99,507 | 47,059 |
| Annual Sales | 20,000 | 8,544,000,000 | 29,803,340,000 | 1,887,100,000 | 2,327,500,000 |
| Annual Net Income | -12,450,000 | 2,344,000,000 | 2,345,930,000 | 249,700,000 | 984,800,000 |
| Last Quarter Sales | 60,000 | 2,213,000,000 | 7,556,070,000 | 515,200,000 | 614,700,000 |
| Last Quarter Net Income | -1,900,000 | 525,000,000 | 718,900,000 | 147,700,000 | 217,100,000 |
| 60-Month Beta | 2.07 | 0.85 | 0.53 | 0.25 | 0.52 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 1.44 on 02/07/24 | 4.36 on 02/21/24 |
| Latest Earnings Date | 11/14/18 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 28.83 | 6.70 | 56.93 | 11.89 |